A Chinese woman suffering from severe epilepsy has died after she independently stopped taking her medication, adhering to a dosage reduction plan suggested by ChatGPT. Her parents have initiated a wrongful death lawsuit, accusing OpenAI and its CEO of unauthorized medical practice and providing dangerous and inaccurate medical guidance. Previously, another user had already taken legal action against OpenAI after experiencing severe injuries due to delayed treatment resulting from incorrect medical advice from ChatGPT. Additionally, attorneys general from eight U.S. states have also filed lawsuits against OpenAI, claiming that ChatGPT misleads users regarding product safety, potentially jeopardizing their health and even encouraging self-harm or harm to others. In response, OpenAI stated that it has removed the model in question, and its new model has enhanced relevant identification and advisory capabilities. The product also includes safety measures tailored for users of different ages and will continue to refine and advocate for the development of industry-related policies. Meanwhile, OpenAI has introduced the ChatGPT Health mode, which segregates health-related discussions from everyday conversations. The platform handles over 230 million health and wellness inquiries weekly, and this mode not only offers health-related answers but also integrates with smart devices to create personalized diet and exercise plans.